Lisata Therapeutics, Inc.LSTANASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank79
3Y CAGR+53.9%
5Y CAGR-19.9%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+53.9%/yr
vs +3.2%/yr prior
5Y CAGR
-19.9%/yr
Recent acceleration
Acceleration
+50.7pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 17.60% |
| 2024 | 3.37% |
| 2023 | 5.38% |
| 2022 | 4.83% |
| 2021 | -152.13% |
| 2020 | 53.27% |
| 2019 | 5.52% |
| 2018 | 4.26% |
| 2017 | 11.80% |
| 2016 | 39.71% |